Synapse

← Gordon B. Mills

Papers by Gordon B. Mills

Page 14 · newest first

  1. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cellsCarcinogenesis · 2006
  2. Carba Analogs of Cyclic Phosphatidic Acid Are Selective Inhibitors of Autotaxin and Cancer Cell Invasion and MetastasisJournal of Biological Chemistry · 2006
  3. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move ForwardClinical Cancer Research · 2006
  4. Phosphorylation of TNF-α converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activationProceedings of the National Academy of Sciences · 2006
  5. Simultaneous Inhibition of PDK1/AKT and Fms-Like Tyrosine Kinase 3 Signaling by a Small-Molecule KP372-1 Induces Mitochondrial Dysfunction and Apoptosis in Acute Myelogenous LeukemiaCancer Research · 2006
  6. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinomaCancer · 2006
  7. Autophosphorylation of Akt at Threonine 72 and Serine 246Journal of Biological Chemistry · 2006
  8. Lysophosphatidic Acid Is a Major Regulator of Growth-Regulated Oncogene α in Ovarian CancerCancer Research · 2006
  9. Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastomaMolecular Cancer Therapeutics · 2006
  10. mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates AktCancer Research · 2006
  11. Assessing BRCA Carrier Probabilities in Extended FamiliesJournal of Clinical Oncology · 2006
  12. Inhibition of the phosphatidylinositol‐3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphomaBritish Journal of Haematology · 2005
  13. Classification of Acute Myelogenous Leukemia (AML) Based on Patterns of Signal Transduction Pathway (STP) and Apoptosis Regulating Protein Activation Determined by Reverse Phase Proteins Arrays (RPPA).Blood · 2005
  14. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastomaMolecular Cancer Therapeutics · 2005
  15. Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and ColonClinical Cancer Research · 2005
  16. Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancerProceedings of the National Academy of Sciences · 2005
  17. Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancerMolecular Cancer Therapeutics · 2005
  18. A Ras Homologue Member I Directly Inhibits Signal Transducers and Activators of Transcription 3 Translocation and Activity in Human Breast and Ovarian Cancer CellsCancer Research · 2005
  19. Methylation and Messenger RNA Expression of p15INK4b but Not p16INK4a Are Independent Risk Factors for Ovarian CancerClinical Cancer Research · 2005
  20. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcomeBMC Cancer · 2005
  21. Microfabricated temperature standard based on Johnson noise measurement for the calibration of micro- and nano-thermometersReview of Scientific Instruments · 2005
  22. Synergistic Augmentation of Rapamycin-Induced Autophagy in Malignant Glioma Cells by Phosphatidylinositol 3-Kinase/Protein Kinase B InhibitorsCancer Research · 2005
  23. Structure−Activity Relationships of Fluorinated Lysophosphatidic Acid AnaloguesJournal of Medicinal Chemistry · 2005
  24. Emerging Role of RAB GTPases in Cancer and Human DiseaseCancer Research · 2005
  25. Role of Glycogen Synthase Kinase 3β in Rapamycin-Mediated Cell Cycle Regulation and ChemosensitivityCancer Research · 2005
  26. Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian CarcinomaMolecular & Cellular Proteomics · 2005
  27. Integrative Epidemiology: From Risk Assessment to Outcome PredictionJournal of Clinical Oncology · 2005
  28. Glycogen Synthase Kinase 3β Is a Negative Regulator of Growth Factor-induced Activation of the c-Jun N-terminal KinaseJournal of Biological Chemistry · 2004
  29. Genes Affecting the Cell Cycle, Growth, Maintenance, and Drug Sensitivity Are Preferentially Regulated by Anti-HER2 Antibody through Phosphatidylinositol 3-Kinase-AKT SignalingJournal of Biological Chemistry · 2004
  30. Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer CellsClinical Cancer Research · 2004
  31. Lysophosphatidic acid production and action: Validated targets in cancer?Journal of Cellular Biochemistry · 2004
  32. Lineage Infidelity of MDA-MB-435 CellsCancer Research · 2004
  33. Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition AnalysisClinical Cancer Research · 2004
  34. Therapeutic potential of phosphoinositide 3-kinase inhibitorsExpert Opinion on Therapeutic Patents · 2004
  35. A Genetically Defined Model for Human Ovarian CancerCancer Research · 2004
  36. Mechanisms for Lysophosphatidic Acid-induced Cytokine Production in Ovarian Cancer CellsJournal of Biological Chemistry · 2004
  37. Determinants of Rapamycin Sensitivity in Breast Cancer CellsClinical Cancer Research · 2004
  38. Enantioselective Responses to a Phosphorothioate Analogue of Lysophosphatidic Acid with LPA3Receptor-Selective Agonist ActivityJournal of Medicinal Chemistry · 2003
  39. Metallic tunable photonic crystal filter for terahertz frequenciesJournal of Vacuum Science & Technology B Microelectronics and Nanometer Structures Processing Measurement and Phenomena · 2003
  40. Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT CascadesJournal of Biological Chemistry · 2003
  41. Modulators of lysophosphatidic acid signallingExpert Opinion on Therapeutic Patents · 2003
  42. Expression of endogenous granzyme B in a subset of human primary breast carcinomasBritish Journal of Cancer · 2003
  43. Evidence That Phosphatidylinositol 3-Kinase- and Mitogen-activated Protein Kinase Kinase-4/c-Jun NH2-terminal Kinase-dependent Pathways Cooperate to Maintain Lung Cancer Cell SurvivalJournal of Biological Chemistry · 2003
  44. Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma CellsJournal of Biological Chemistry · 2003
  45. Identification of a Phosphothionate Analogue of Lysophosphatidic Acid (LPA) as a Selective Agonist of the LPA3 ReceptorJournal of Biological Chemistry · 2003
  46. Insulin-Like Growth Factor-I Inhibits Progesterone Receptor Expression in Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway: Progesterone Receptor as a Potential Indicator of Growth Factor Activity in Breast CancerMolecular Endocrinology · 2003
  47. Transcriptional Activation of the Proglucagon Gene by Lithium and β-Catenin in Intestinal Endocrine L CellsJournal of Biological Chemistry · 2003
  48. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid productionThe Journal of Cell Biology · 2002
  49. Pretest Prediction of BRCA1 or BRCA2 Mutation by Risk Counselors and the Computer Model BRCAPROJNCI Journal of the National Cancer Institute · 2002
  50. Use of Proteomic Patterns in Serum to Identify Ovarian CancerObstetrical & Gynecological Survey · 2002